Funding the first copy

If we want to enable free access to knowledge goods, we need to find ways to finance the first copy. The industrial business model has been to regard the costs of the first copy as up-front investment that is later recouped by controlling access to subsequent copies. This model is clearly broken, if everyone can make copies, or if the resulting price of the copies is so high, that people who need them, cannot afford it. As is the case with many drugs, particularly, but not only, in the developing world.